Schizophrenia from a functional neuroimaging point of view metabolic and perfusion studies;Schizofrenie v obraze funkčních zobrazovacích metod metabolické a perfuzní studie

Psychiatrie

Volumn 6, Issue SUPPL. 4, 2002, Pages 35-41

  Kopeček, Miloslav ^a   Horáček, Jiří ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

Author keywords

fMR; Functional imaging methods; PET; Schizophrenia; SPECT

Indexed keywords

NEUROLEPTIC AGENT;

ATTENTION; BRAIN FUNCTION; BRAIN METABOLISM; CINGULATE GYRUS; COGNITION; CONFERENCE PAPER; DIAGNOSTIC IMAGING; DISORIENTATION; FRONTAL CORTEX; HUMAN; MEMORY; NEGATIVE SYNDROME; PHOTOSTIMULATION; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; QUALITATIVE DIAGNOSIS; QUANTITATIVE DIAGNOSIS; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOMATOLOGY; TEMPORAL CORTEX;

EID: 0036334117     PISSN: 12117579     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (63)

1. Defining the phenotype of schizophrenia: Cognitive dysmetria and its neural mechanisms
2. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London
3. Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia
4. Striatal metabolic rate and clinical response to neuroleptics in schizophrenia
5. PET and MRI of the thalamus in never-medicated patients with schizophrenia
6. Prefrontal and temporal blood flow in schizophrenia: Resting and activation technetium-99m-HMPAO SPECT patterns in young neuroleptic-naive patients with acute disease
7. Toward a brain map of auditory hallucinations
8. Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia
9. Abnormalities in the distributed network of sustained attention predict neuroleptic treatment response in schizophrenia
10. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia
11. Dorsolateral prefrontal cortex dysfunction in the major psychoses; symptom or disease specificity?
12. Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia
13. Single-photon emission computed tomography with 99mTc-exametazime in unmedicated schizophrenic patients
14. Hypofrontality revisited: A high resolution single photon emission computed tomography study in schizophrenia
15. Active and remitted schizophrenia: Psychopathological and regional cerebral blood flow findings
16. Abnormal cingulate modulation of fronto-temporal connectivity in schizophrenia
17. Local and distributed effects of apomorphine on fronto-temporal function in acute unmedicated schizophrenia
18. Hypofrontality in schizophrenia: RIP
19. Laterality in functional brain imaging studies of schizophrenia
20. Laterality and frontality of cerebral blood flow and metabolism in schizophrenia: Relationship to symptom specificity
21. Regional brain function in schizophrenia. II. Repeated evaluation with positron emission tomography
22. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol
23. Novel antipsychotics and extrapyramidal side effects. (Theory and reality.)
24. Informační processing, neuronální sítě a modelování psychopatologie
25. Vliv deplece tryptofanu na kognitivní funkce a na funkční zobrazení mozku (fMR)
26. Vztah serotonergní neurotransmise a metabolismu mozku u schizofrenie. Studie fMR a PET
27. Regionální metabolismus mozku (18-FDG-PET) a domény schizofrenní symptomatiky
28. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia
29. Blood flow patterns induced in the dominant hemisphere by speech and reading
30. Funkční magnetická rezonance a evokovné potenciály - Základní principy a aplikace
31. Three clinical syndromes of schizophrenia in untreated subjects: Relation to brain glucose activity measured by positron emission tomography (PET)
32. Regional neural dysfunctions in chronic schizophrenia studied with positron emission tomography
33. Funkční zobrazovací metody v neuropsychiatrii: Metody, možnosti a omezení
34. Zobrazovací metody v psychiatrii
35. Regionální perfuze mozku pacientky s první epizodou schizofrenie před a během léčby risperidonem
36. Psychopatologie a metabolismus mozku (18FDG-PET) u pacientů se schizofrenií
37. Vyšetření regionální mozkové perfuze pomocí jednofotonové emisní tomografie (SPECT) v psychiatrii
38. Patterns of cerebral blood flow in schizophrenia
39. Immediate effects of risperidone on cortico-striato-thalamic loops and the hippocampus
40. Increased blood flow in Broca's area during auditory hallucinations in schizophrenia
41. Similarities in the pattern of regional brain dysfunction in negative schizophrenia and unipolar depression: A single photon emission-computed tomography and auditory evoked potentials study
42. Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia
43. The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: Assessment with technetium-99m hexamethyl-propyleneamine oxime single photon emission computed tomography
44. Prefrontal dysfunction in young acute neuroleptic-naive schizophrenic patients: A resting and activation SPECT study
45. Clozapine effects on glucose metabolic rate in striatum and frontal cortex
46. Functional neuroimaging of neuropsychologically impaired Patiens
47. SPECT neuroimaging in schizophrenia with religious delusions
48. Fronto-striato-thalamic perfusion and clozapine response in treatment-refractory schizophrenic patients. A 99mTc-HMPAO study
49. Temporal lobe perfusion asymmetries in schizophrenia
50. Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics
51. Frontality, laterality, and cortical-subcortical gradient of cerebral blood flow in schizophrenia: Relationship to symptoms and neuropsychological functions
52. Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia
53. Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging
54. A functional neuroanatomy of hallucinations in schizophrenia
55. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia
56. Vulnerability to tardive dyskinesia development in schizophrenia: An FDG-PET study of cerebral metabolism
57. A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia?
58. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome
59. Regional cerebral blood flow in deficit/nondeficit types of schizophrenia according to SDS criteria
60. High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients
61. Low cerebellar metabolism in medicated patients with chronic schizophrenia
62. Negative symptoms and hypofrontality in chronic schizophrenia
63. Clinical symptoms and regional cerebral blood flow in schizophrenia